vTv Therapeutics (VTVT) EBITDA Margin Growth (1y) (2015 - 2022)
Powered by 
Analysis
vTv Therapeutics (VTVT) EBITDA Margin Growth (1y) (2015 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 1,238.00 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -194.00 |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 5.30 Mn |
| Jun 30, 2022 | 714,444.00 |
| Mar 31, 2022 | 10,959.00 |
| Dec 31, 2021 | -12.35 Mn |
| Sep 30, 2021 | 4.04 Mn |
| Mar 31, 2021 | 8.26 Mn |
| Dec 31, 2020 | 9.13 Mn |
| Sep 30, 2020 | 2.74 Mn |
| Mar 31, 2020 | -8.26 Mn |
| Dec 31, 2019 | -9.12 Mn |
| Sep 30, 2019 | -6.78 Mn |
| Jun 30, 2019 | 9,604.00 |
| Mar 31, 2019 | -2,293.00 |
| Dec 31, 2018 | 547,378.00 |
| Sep 30, 2018 | 7.69 Mn |
| Jun 30, 2018 | 9.67 Mn |
| Mar 31, 2018 | 4.54 Mn |
| Dec 31, 2017 | 2.96 Mn |
| Sep 30, 2017 | -4.13 Mn |
| Jun 30, 2017 | -8.90 Mn |